Skip to content

Avery Dennison AVY Vancive Medical Technologies — Goodwill

Discontinued — last reported Q3 '16

Similar metrics at other companies

TEC
TECHOperating Segments — Goodwill
$430.88M+10.3%
Ball Corporation logo
BALLAerospace And Technologies — Goodwill
$40M0.0%
IR
IRMedical — Goodwill
$203.2M0.0%
Crane Co. logo
CRPayment & Merchandising Technologies — Goodwill
$837.8M
Agilent Technologies logo
ALife Sciences and Applied Markets — Goodwill
$1.58B+0.3%
Fortive logo
FTVOperating Segments — Goodwill
$4.05B

Other financials

Income statement

See full
Revenue$2.3B+7.0%
Gross profit$664.8M+7.0%
Net income$168.1M+1.1%
EPS (diluted)$2.18+4.3%

Balance sheet

See full
Cash & equivalents$255.1M+30.2%
Total debt$3.8B+9.6%
Total equity$2.3B+6.0%
Total assets$9.0B+7.5%

Cash flow

See full
Operating cash flow$136.5M+937%
CapEx$28.3M-21.4%
Free cash flow$108.2M+307%

Valuation

See full
Market cap$12.14B-5.5%
Enterprise value$15.67B-2.9%
P/E17.6×-0.8×
P/S1.4×-0.1×

Profitability

See full
Gross margin28.8%0.0pp
Net margin7.7%-0.3pp
FCF margin9.7%+2.8pp

Returns & leverage

See full
Return on equity30.9%-1.1pp
Debt / equity1.6×+0.1×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by Avery Dennison in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Avery Dennison’s 10-Q, filed November 1, 2016, on SEC EDGAR. View the filing →

Questions, answered.

What does vancive medical technologies — goodwill mean?
The value of intangible assets like brand and intellectual property recorded on the balance sheet for the medical technologies segment.
How do you interpret vancive medical technologies — goodwill?
Stable or growing goodwill suggests successful integration of acquisitions, while a sudden decrease signals potential impairment and a decline in the segment's long-term earnings potential.
How does vancive medical technologies — goodwill compare across companies?
Most diversified manufacturing companies report segment-level goodwill, which is compared against industry benchmarks for acquisition premiums and asset valuation health.